Research location
Grafton
Auckland, New Zealand
Advertisement
Research activity in Grafton
Auckland, New ZealandCureCurrent currently publishes aggregate city-level research activity for this location: 25 trials and 25 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Grafton
25 linked trials · page 1 of 1DIAG723 in Adults With Hereditary Hemorrhagic TelangiectasiaNCT07623525 · 2026-06-04 · 1 site observation
RECRUITING
Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's DiseaseNCT07221344 · 2025-11-18 · 1 site observation
RECRUITING
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes MellitusNCT06937203 · 2025-05-09 · 1 site observation
RECRUITING
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)NCT06881784 · 2025-05-06 · 1 site observation
RECRUITING
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes MellitusNCT06700538 · 2024-12-04 · 1 site observation
RECRUITING
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)NCT06520345 · 2024-07-26 · 1 site observation
RECRUITING
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaNCT05235165 · 2022-04-01 · 1 site observation
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and DiabetesNCT07284901 · 2026-01-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have DiabetesNCT07284875 · 2025-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Comparative Study of 3 Tocilizumab Products in Normal Healthy VolunteeersNCT04885829 · 2021-05-31 · 1 site observation
COMPLETED
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural MesotheliomaNCT04334759 · 2021-02-18 · 1 site observation
COMPLETED
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)NCT03924869 · 2019-06-25 · 1 site observation
TERMINATED
PeriOperative ISchemic Evaluation-3 TrialNCT03505723 · 2018-06-27 · 1 site observation
COMPLETED
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic FunctionNCT03417778 · 2018-04-03 · 1 site observation
COMPLETED
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid TumorsNCT02926768 · 2016-09-01 · 1 site observation
COMPLETED
Carvedilol in Preventing Heart Failure in Childhood Cancer SurvivorsNCT02717507 · 2016-04-04 · 1 site observation
COMPLETED
A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 ExpressionNCT02512237 · 2016-03-01 · 1 site observation
TERMINATED
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaNCT02484443 · 2016-02-04 · 1 site observation
COMPLETED
Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal FunctionNCT02400307 · 2015-04-17 · 1 site observation
COMPLETED
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver DecompensationNCT01687257 · 2012-07-01 · 1 site observation
COMPLETED
Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty CatheterNCT01541865 · 2012-02-01 · 1 site observation
COMPLETED
A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung CancerNCT01189968 · 2010-09-01 · 1 site observation
COMPLETED
A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line RegimenNCT00931463 · 2009-09-01 · 1 site observation
COMPLETED
IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD PatientsNCT00567398 · 2008-04-01 · 1 site observation
COMPLETED
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)NCT00310180 · 2006-04-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.